Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-26 @ 4:00 AM
Study NCT ID:
NCT01203618
Status:
WITHDRAWN
Last Update Posted:
2013-11-04
First Post:
2010-07-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
Sponsor:
Morphotek
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2013-08
Completion Date Type:
ESTIMATED
First Submit Date:
2010-07-28
First Submit QC Date:
None
Study First Post Date:
2010-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-01
Last Update Post Date:
2013-11-04
Last Update Post Date Type:
ESTIMATED